Journals / Cukurova Medical Journal / 2022 / Cilt: 47 - Sayı: 2

Effect of N-acetylcysteine on cisplatin induced apoptosis in rat kidney

N-asetilsisteinin rat böbreklerinde sisplatin ile indüklenen apoptoz üzerine etkisi

Pages
519–525
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: These data suggest that apoptotic cell death is involved in the pathogenesis of cisplatin-induced nephrotoxicity, and that the inhibition of apoptosis plays a central role in the beneficial effects of NAC.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Cisplatin is one of the most potent and widely used chemotherapeutic agents for the treatment of a wide variety of solid organ cancers.
📊
Key Findings & Data:Materials and Methods: Twentyfour male Wistar rats were separated into 4 equal groups: Control, NAC-250, cisplatin (CP), and CP+NAC groups.
💡
Conclusion & Impact:Conclusion: These data suggest that apoptotic cell death is involved in the pathogenesis of cisplatin-induced nephrotoxicity, and that the inhibition of apoptosis plays a central role in the beneficial effects of NAC.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: Cisplatin is one of the most potent and widely used chemotherapeutic agents for the treatment of a wide variety of solid organ cancers. However, due to various side-effects such as nephrotoxicity, its therapeutic applications are limited. In the current study, it was aimed to investigate the effects of N-acetylcysteine (NAC), which is an effective antioxidant and anti-inflammatory agent, on cisplatin-induced apoptosis in rat kidneys. Materials and Methods: Twentyfour male Wistar rats were separated into 4 equal groups: Control, NAC-250, cisplatin (CP), and CP+NAC groups. Rats in the experimental groups were treated with intraperitoneally (i.p.) single-dose cisplatin (10 mg/kg) and NAC (i.p., 250 mg/kg) for 3 days. Results: At the end of the experiment, nephrotoxicity was confirmed by blood urea nitrogen and creatinine levels, and the apoptotic changes were demonstrated by TdT-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) and caspase-3 levels in rat kidneys. The number of TUNEL-positive cells and caspase-3 levels were significantly increased by cisplatin. Treating the rats with NAC significantly decreased TUNEL-positive cells and caspase-3 levels. Conclusion: These data suggest that apoptotic cell death is involved in the pathogenesis of cisplatin-induced nephrotoxicity, and that the inhibition of apoptosis plays a central role in the beneficial effects of NAC.

Özet

için en güçlü ve yaygın olarak kullanılan kemoterapötik ajanlardan biridirAncak nefrotoksisite gibi çeşitli yan etkileri nedeniyle terapötik uygulamaları sınırlıdır. Bu çalışmada, etkili bir antioksidan ve antienflamatuar ajan olan N-asetilsistein (NAC)’in rat böbreklerinde sisplatin kaynaklı apoptoz üzerindeki etkilerinin araştırılması amaçlanmıştır. Gereç ve Yöntem: Wistar cinsi erkek ratlar eşit sayıda olacak şekilde 4 gruba ayrıldı: Kontrol, NAC-250, sisplatin (CP) ve CP+NAC.Gruplardaki ratlara tek doz sisplatin (10 mg/kg) ve 3 gün NAC (250 mg/kg) intraperitoneal (i.p.) olarak uygulandı. Bulgular: Deneyin sonunda, nefrotoksisite, kan üre nitrojen ve kreatinin seviyeleri ile doğrulandı ve apoptotik değişiklikler, sıçan böbreklerinde TdT aracılı deoksiüridin trifosfat nick-end etiketleme (TUNEL) ve kaspaz-3 seviyeleri ile gösterildi. TUNEL pozitif hücre sayısı ve kaspaz-3 seviyeleri sisplatin ile önemli ölçüde arttı. Sıçanları NAC ile tedavi etmek, TUNEL pozitif hücreleri ve kaspaz-3 seviyelerini önemli ölçüde azalttı. Sonuç: Bu veriler, apoptotik hücre ölümünün sisplatin ile indüklenen nefrotoksisitenin patogenezinde etkili olduğunu ve apoptoz inhibisyonunun NAC'ın faydalı etkilerinde merkezi bir rol oynadığını göstermektedir.

🔖

Cite This Article

GÜNTÜRK, İ., SEYDEL, G. Ş., DAĞLI, F., YAZICI, C., KÖSE, K., YAY, A. (2022). Effect of N-acetylcysteine on cisplatin induced apoptosis in rat kidney. Cukurova Medical Journal, Cilt: 47 - Sayı: 2, 519–525. https://ajindex.com/articles/476754

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Dilruba S, Kalayda G. Platinum‑based drugs: past, present and future. Cancer Chemother Pharmacol. 2016;77:1103-24
  2. Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel). 2010;2:2490-518
  3. Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 2008;73:994-1007
  4. Almanric K, Marceau N, Cantin A, Bertin É. Risk factors for nephrotoxicity associated with cisplatin. Can J Hosp Pharm. 2017;70:99-106
  5. Nho JH, Jung HK, Lee MJ, Jang JH, Sim MO, Jeong DE et al. Beneficial effects of cynaroside on cisplatininduced kidney injury in vitro and in vivo. Toxicol Res. 2018;34:133-41
  6. Lau AH. Apoptosis induced by cisplatin nephrotoxic injury. Kidney Int. 1999;56:1295-8
  7. Kaushal GP, Kaushal V, Herzog C, Yang C. Autophagy delays apoptosis in renal tubular epithelial cells in cisplatin cytotoxicity. Autophagy. 2008;4:710- 2
  8. Hanigan MH, Devarajan P. Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther. 2003;1:47-61
  9. Manohar S, Leung N. Cisplatin nephrotoxicity: a review of the literature. J Nephrol. 2018;31:15-25
  10. Mi XJ, Hou JG, Wang Z, Han Y, Ren S, Hu JN, et al. The protective effects of maltol on cisplatin-induced nephrotoxicity through the AMPK mediated pi3k/akt and p53 signaling pathways. Sci Rep. 2018;8:15922
  11. Vermeulen K, Van Bockstaele DR, Berneman ZN. Apoptosis: mechanisms and relevance in cancer. Ann Hematol. 2005;84:627-39
  12. Tanase DM, Gosav EM, Radu S, Costea CF, Ciocoiu M, Carauleanu A et al. The predictive role of the biomarker kidney molecule-1 (KIM-1) in acute kidney injury (AKI) cisplatin-induced nephrotoxicity. Int J Mol Sci. 2019;20:5238
  13. Aldini G, Altomare A, Baron G, Vistoli G, Carini M, Borsani L et al. N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why. Free Radic Res. 2018;52:751-62
  14. Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA. N-Acetylcysteine--a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol. 2007;7: 355-9
  15. Güntürk İ, Yazıcı C, Köse SK, Dağlı F, Yücel B, Yay AH. The effect of N-acetylcysteine on inflammation and oxidative stress in cisplatin-induced nephrotoxicity: a rat model. Turk J Med Sci 2019;49:1789-99
  16. Wu YJ, Muldoon LL, Neuwelt EA. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway. J Pharmacol Exp Ther. 2005;312:424-31
  17. Luo J, Tsuji T, Yasuda H, Sun Y, Fujigaki Y, His